BIOSYNEX announces that it has signed a binding offer to acquire 100% of the shares of AVALUN
BIOSYNEX, which has established itself with the COVID-19 pandemic as a key player in decentralized biology, is highly complementary to AVALUN. By joining the BIOSYNEX group, Avalun intends to take part in the objective of becoming a leading global player in the point of care field. Larry Abensur, CEO of BIOSYNEX: “We are delighted with […]